Policy Recommendations Massachusetts

2019-2020 Improvements and Recommendations for Massachusetts

In 2019, the Massachusetts Cannabis Control Commission (CCC) approved regulations providing for operation of new public consumption facilities and for delivery operations of adult-use cannabis. Additional state legislation is required to enable the rollout of consumption facilities, which will also require approval from local governments where facility operators are looking to deploy these new business models. While 2019 and 2020 were primarily focused on modifications to the nascent state adult-use system, enrollment in Massachusetts' medical cannabis program continues to steadily grow.

2020 also saw the CCC consider removing vertical integration requirements for medical retail facilities to also serve as cultivators, along with more stringent rules for facilities that fail testing for pesticides and heavy metals. Both are welcomed improvements, and regulators are expected to issue new rules related to these items before the end of the year. Beyond these changes ASA recommends that Massachusetts lawmakers and regulators work to improve consumer protections and product testing and labeling standards.

Massachusetts maintained patient access to medical retail facilities as part of the Commonwealth's COVID emergency response, and authorized curbside pickup and certification of new patients via telehealth. Delivery of medical cannabis to patients was also maintained under these measures.